Acute cardiac care & resuscitationCohort study

Association Between Hospital Tier and Cardiogenic Shock Outcomes in the United States

JACC Heart FailPublished

  • Retrospective cohort study
  • Nationwide Readmissions Database (2016-2022)
  • multinomial overlap propensity adjustment
  • hierarchical regression models

Authors' conclusion

Tiered CS care was associated with a stepwise improvement in survival outcome at advanced centers despite greater acuity of illness.

Study context

Population
Adults (≥18 years) hospitalized with cardiogenic shock, US, 2016–2022
Participants
623,835 cardiogenic shock (CS) admissions
Exposure
CS centre levels 1A, 2 and 3 vs level 1
Outcome
In-hospital mortality

Main finding

As reported in the abstract

Each group vs level 1Adjusted odds ratio (95% CI)P value
Level 1A
1.33(1.29–1.38)
P < 0.001
Level 2
1.44(1.38–1.50)
P < 0.001
Level 3
1.63(1.54–1.71)
P < 0.001

Observational data: associations, not effects.

Further findings

OutcomeEstimate
Receipt of MCS — Level 1A vs Level 1 · 38% loweraOR 0.62 (95% CI 0.59–0.65)
Receipt of MCS — Level 2 vs Level 1 · 73% loweraOR 0.27 (95% CI 0.25–0.28)
30-day readmissions (survivors) · 30 days — Level 1A vs Level 1 · lower by 4%OR 0.96 (95% CI 0.94–0.98)
30-day readmissions (survivors) · 30 days — Level 2 vs Level 1 · no significant differenceOR 1.02 (95% CI 0.99–1.06)
OutcomeOR (95% CI)
30-day readmissions (survivors) · 30 days — Level 3 vs Level 1 · lower by 1%0.99 (0.94–0.98)

In-hospital mortality by subgroup (age, cardiac arrest, mechanical circulatory support (MCS) use, location, insurance)

Survival benefit of level 1 centres persisted across subgroups

Length of stay and costs

Higher at levels 1 and 1A

Original publication

Association Between Hospital Tier and Cardiogenic Shock Outcomes in the United States. JACC Heart Fail. Published 9 May 2026. doi:10.1016/j.jchf.2026.103100

Summarised from the published abstract; every number is checked against it